We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
2 similar License and Collaboration Agreement contracts by Lexicon Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc./De
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • December 23rd, 2014 • Lexicon Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This License and Collaboration Agreement (this “Agreement”), dated the 21st day of October, 2014 (the “Effective Date”), is by and between Ipsen PHARMA SAS, a French corporation with its principal offices at 65 Quai Georges Gorse, Boulogne-Billancourt 92100, France (“Ipsen”), and Lexicon Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 8800 Technology Forest Place, The Woodlands, Texas 77381 U.S.A. (“Lexicon”).
Standard Contracts
LICENSE AND COLLABORATION AGREEMENTLicense and Collaboration Agreement • November 6th, 2014 • Lexicon Pharmaceuticals, Inc./De • Pharmaceutical preparations • New York
This License and Collaboration Agreement (this “Agreement”), dated the 21st day of October, 2014 (the “Effective Date”), is by and between Ipsen PHARMA SAS, a French corporation with its principal offices at 65 Quai Georges Gorse, Boulogne-Billancourt 92100, France (“Ipsen”), and Lexicon Pharmaceuticals, Inc., a Delaware corporation with its principal offices at 8800 Technology Forest Place, The Woodlands, Texas 77381 U.S.A. (“Lexicon”).